385 related articles for article (PubMed ID: 31410188)
21. Autophagy Induction by Trichodermic Acid Attenuates Endoplasmic Reticulum Stress-Mediated Apoptosis in Colon Cancer Cells.
Qu J; Zeng C; Zou T; Chen X; Yang X; Lin Z
Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34070303
[TBL] [Abstract][Full Text] [Related]
22. Fangchinoline exerts anticancer effects on colorectal cancer by inducing autophagy via regulation AMPK/mTOR/ULK1 pathway.
Xiang X; Tian Y; Hu J; Xiong R; Bautista M; Deng L; Yue Q; Li Y; Kuang W; Li J; Liu K; Yu C; Feng G
Biochem Pharmacol; 2021 Apr; 186():114475. PubMed ID: 33609560
[TBL] [Abstract][Full Text] [Related]
23. Targeting CDK9 for treatment of colorectal cancer.
Rahaman MH; Lam F; Zhong L; Teo T; Adams J; Yu M; Milne RW; Pepper C; Lokman NA; Ricciardelli C; Oehler MK; Wang S
Mol Oncol; 2019 Oct; 13(10):2178-2193. PubMed ID: 31398271
[TBL] [Abstract][Full Text] [Related]
24. Sea Cucumber (
Kim JL; Park SH; Jeong S; Kim BR; Na YJ; Jo MJ; Jeong YA; Yun HK; Kim DY; Kim BG; You S; Oh SC; Lee DH
Nutrients; 2019 May; 11(5):. PubMed ID: 31083595
[TBL] [Abstract][Full Text] [Related]
25. P-glycoprotein and breast cancer resistance protein restrict brigatinib brain accumulation and toxicity, and, alongside CYP3A, limit its oral availability.
Li W; Sparidans RW; Wang Y; Lebre MC; Beijnen JH; Schinkel AH
Pharmacol Res; 2018 Nov; 137():47-55. PubMed ID: 30253203
[TBL] [Abstract][Full Text] [Related]
26. Exploratory Analysis of Brigatinib Activity in Patients With Anaplastic Lymphoma Kinase-Positive Non-Small-Cell Lung Cancer and Brain Metastases in Two Clinical Trials.
Camidge DR; Kim DW; Tiseo M; Langer CJ; Ahn MJ; Shaw AT; Huber RM; Hochmair MJ; Lee DH; Bazhenova LA; Gold KA; Ou SI; West HL; Reichmann W; Haney J; Clackson T; Kerstein D; Gettinger SN
J Clin Oncol; 2018 Sep; 36(26):2693-2701. PubMed ID: 29768119
[TBL] [Abstract][Full Text] [Related]
27. Brigatinib: First Global Approval.
Markham A
Drugs; 2017 Jul; 77(10):1131-1135. PubMed ID: 28597393
[TBL] [Abstract][Full Text] [Related]
28. Activity of Brigatinib in the Setting of Alectinib Resistance Mediated by ALK I1171S in ALK-Rearranged Lung Cancer.
Sehgal K; Peters MLB; VanderLaan PA; Rangachari D; Kobayashi SS; Costa DB
J Thorac Oncol; 2019 Jan; 14(1):e1-e3. PubMed ID: 29981924
[No Abstract] [Full Text] [Related]
29. CYT997(Lexibulin) induces apoptosis and autophagy through the activation of mutually reinforced ER stress and ROS in osteosarcoma.
Wang Z; Yin F; Xu J; Zhang T; Wang G; Mao M; Wang Z; Sun W; Han J; Yang M; Jiang Y; Hua Y; Cai Z
J Exp Clin Cancer Res; 2019 Jan; 38(1):44. PubMed ID: 30704503
[TBL] [Abstract][Full Text] [Related]
30. A Novel Mechanism of Endoplasmic Reticulum Stress- and c-Myc-Degradation-Mediated Therapeutic Benefits of Antineurokinin-1 Receptor Drugs in Colorectal Cancer.
Shi Y; Wang X; Meng Y; Ma J; Zhang Q; Shao G; Wang L; Cheng X; Hong X; Wang Y; Yan Z; Cao Y; Kang J; Fu C
Adv Sci (Weinh); 2021 Nov; 8(21):e2101936. PubMed ID: 34605226
[TBL] [Abstract][Full Text] [Related]
31. Management of Central Nervous System Metastases in Patients With Advanced Anaplastic Lymphoma Kinase-Rearranged Non-Small-Cell Lung Cancer During Crizotinib Treatment.
Zhao Y; Zhang B; Wang S; Qiao R; Xu J; Zhang L; Zhang Y; Han B
Clin Lung Cancer; 2019 Nov; 20(6):e631-e637. PubMed ID: 31362880
[TBL] [Abstract][Full Text] [Related]
32. Ceritinib ALK T1151R Resistance Mutation in Lung Cancer With Initial Response to Brigatinib.
Mehlman C; Chaabane N; Lacave R; Kerrou K; Ruppert AM; Cadranel J; Fallet V
J Thorac Oncol; 2019 May; 14(5):e95-e96. PubMed ID: 31027750
[No Abstract] [Full Text] [Related]
33. Brigatinib treated ALK positive lung squamous cell carcinoma after failed chemotherapy: A case report.
Li S; Zhang P; Wang T; Wang J; Duan J
Thorac Cancer; 2021 Dec; 12(23):3273-3276. PubMed ID: 34647426
[TBL] [Abstract][Full Text] [Related]
34. A novel ALK inhibitor ZYY inhibits Karpas299 cell growth in vitro and in a mouse xenograft model and induces protective autophagy.
Shen J; Wang J; Du J; Wang L; Zhou X; Chang X; Li Z; Zhai X; Zuo D; Wu Y
Toxicol Appl Pharmacol; 2019 Nov; 383():114781. PubMed ID: 31618659
[TBL] [Abstract][Full Text] [Related]
35. Brigatinib-induced tuberculosis reactivation: A case report.
Keş V; Sütcüoğlu O; Gürler F; Yazıcı O; Özet A
Curr Probl Cancer; 2021 Dec; 45(6):100738. PubMed ID: 33867154
[TBL] [Abstract][Full Text] [Related]
36. Zebularine inhibits tumorigenesis and stemness of colorectal cancer via p53-dependent endoplasmic reticulum stress.
Yang PM; Lin YT; Shun CT; Lin SH; Wei TT; Chuang SH; Wu MS; Chen CC
Sci Rep; 2013 Nov; 3():3219. PubMed ID: 24225777
[TBL] [Abstract][Full Text] [Related]
37. Differential Chemoproteomics Reveals MARK2/3 as Cell Migration-Relevant Targets of the ALK Inhibitor Brigatinib.
Hu Q; Liao Y; Cao J; Fang B; Yun SY; Kinose F; Haura EB; Lawrence HR; Doebele RC; Koomen JM; Rix U
Chembiochem; 2023 Jun; 24(11):e202200766. PubMed ID: 36922348
[TBL] [Abstract][Full Text] [Related]
38. Brigatinib in Patients With Crizotinib-Refractory Anaplastic Lymphoma Kinase-Positive Non-Small-Cell Lung Cancer: A Randomized, Multicenter Phase II Trial.
Kim DW; Tiseo M; Ahn MJ; Reckamp KL; Hansen KH; Kim SW; Huber RM; West HL; Groen HJM; Hochmair MJ; Leighl NB; Gettinger SN; Langer CJ; Paz-Ares Rodríguez LG; Smit EF; Kim ES; Reichmann W; Haluska FG; Kerstein D; Camidge DR
J Clin Oncol; 2017 Aug; 35(22):2490-2498. PubMed ID: 28475456
[TBL] [Abstract][Full Text] [Related]
39. Simultaneous inhibition of the ubiquitin-proteasome system and autophagy enhances apoptosis induced by ER stress aggravators in human pancreatic cancer cells.
Li X; Zhu F; Jiang J; Sun C; Zhong Q; Shen M; Wang X; Tian R; Shi C; Xu M; Peng F; Guo X; Hu J; Ye D; Wang M; Qin R
Autophagy; 2016 Sep; 12(9):1521-37. PubMed ID: 27308733
[TBL] [Abstract][Full Text] [Related]
40. Brigatinib versus crizotinib for ALK-positive NSCLC.
Stirrups R
Lancet Oncol; 2018 Nov; 19(11):e585. PubMed ID: 30293790
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
